Purchase Order HHSN271201500621P

This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...

This is a firm-fixed-price purchase order for $149,960.58 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Analyticon Discovery, LLC, a foreign-owned for-profit organization. The contract is set aside for small businesses and is part of the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program. The contract is for the delivery of products and services related to small molecules for NCATS' pharmacologically active...

This federal contract award was issued by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Cayman Chemical Co Inc., a small business manufacturer of biochemical products and research tools. The $132,476.28 firm fixed-price purchase order is for the supply of "Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT)," which supports NCATS' drug discovery and translational research initiatives. Cayman...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...

This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business based in New Jersey. The $84,954 firm-fixed-price purchase order is for the provision of small molecules to support NCATS' Pharmacologically Active Chemical Toolbox (NPACT) program, which focuses on developing and evaluating chemical compounds for biomedical research. The...

<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>

<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $452,500.00 firm fixed-price purchase order contract to Chemroutes Corporation, a foreign-owned for-profit organization, for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program. The contract has an ultimate completion date of April 30, 2016 and was awarded on December 23, 2015. This contract was not set aside for any particular business type.</p>

<p>This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Santa Cruz Biotechnology Inc., a self-certified small disadvantaged business, for Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) on a Firm Fixed Price basis. The contract has a potential value of $83,645.95 and a completion date of November 30, 2015. No set-aside was used for this award.</p>

This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the &quot;SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)&quot; program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.

This is a $376,706 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business located in New Jersey. The contract supports the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program, providing chemical compounds and other scientific inputs for the agency's biomedical research initiatives....